Home > Products > CD44 & CR3 > Anti-CD44 x Anti-CR3 Bispecific Antibody (IgG-IgG)

Anti-CD44 x Anti-CR3 Bispecific Antibody (IgG-IgG)  (BSIG-H293)

Anti-CD44 x Anti-CR3 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD44 and anti-CR3 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can recruit macrophages to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.

Datasheet
Specifications
Targets
CD44 & CR3
Type
IgG-IgG
Species Reactivity
Human
Target 1
CD44
Host Animal 1
Human
Target 2
CR3
Host Animal 2
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Glioblastoma; Squamous cancer
Targets
Target 1
CD44
Gene ID
960
UniProt ID
P16070
Alternative Names
CD44; CD44 antigen; ECMRIII; Extracellular matrix receptor III; HCAM; Homing cell adhesion molecule; Pgp-1; phagocytic glycoprotein-1; HUTCH-1; Ly-24; Pgp-1; HERMES; AU023126; AW121933; AW146109
Target 2
CR3
Gene ID
719
UniProt ID
Q16581
Alternative Names
C3AR1; complement C3a receptor 1; AZ3B; C3AR; HNFAG09; CR3; Complement receptor type 3; CD11b/CD18; Mac-1; Macrophage antigen 1; αmβ2
Our services and products are only for lab research, not for any diagnostic or therapeutic use.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Online Inquiry
Verification code
Click image to refresh the verification code.
USA
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

Germany
Heidenkampsweg 58, 20097 Hamburg, Germany
Email:

UK
167-169 Great Portland Street, 5th Floor, London, W1W 5PE
Tel: 44-207-097-1828
Email:
Related products of "CD44 & CR3"
45-1 Ramsey Road, Shirley, NY 11967, USA 1-631-381-2994 1-631-207-8356
24x7 CUSTOMER SERVICE
Easy access to products and services you need from our library via
powerful searching tools
© 2007 - 2021 Creative-Biolabs All Rights Reserved. Distributors
To view the contact information for a specific location,
select your country or region: